Corporate Finance

Frazier Life Sciences just closed a $1.1B+ oversubscribed fund. This isn't just another raise; it's a masterclass in navigating biotech volatility.

As Stewards Inc. moves from the OTC markets to Nasdaq, its journey reflects the mainstreaming of alternative finance and poses key questions for investors.

In a volatile climate, Apogem Capital's oversubscribed fund highlights institutional confidence in a niche strategy targeting private equity's resilient heartland.

While most crypto projects sell a vision, Remittix is building a live financial ecosystem—and it's already processing millions before its token even lists.

As giants like BlackRock pour billions into Bitcoin, a shadowy world of presales promises 100x returns. But what happens when the hype is built on an illusion?

OMVP's investment in HyImpulse signals a pivotal moment for Europe's space ambitions, backing hybrid-rocket tech to secure independent orbital access.

As a wall of maturing debt challenges commercial real estate, private credit firms like BridgeInvest are stepping in to fill a critical financing gap.

With $26M in fresh funding, Metriport is turning fragmented patient data into life-saving clinical intelligence. We decode why AI and open-source are key signals.

A startup just raised $7M to unleash autonomous robot interceptors against the FPV drone nightmare. Is this the future of defense or a new ethical precipice?

With a major investment and novel molten-salt tech, Mantel aims to finally crack the code on cost, making carbon capture a profitable reality for industry.

With a $115M financing and an expanded pipeline, Assembly Biosciences is betting on novel therapies for liver and viral diseases. But can it navigate a crowded field?

Zakat Coin's record-breaking IEO shows strong demand for ethical, utility-driven crypto. The project merges payments, remittance, and charity on the blockchain.

Local Bounti posts 14% revenue growth and narrows losses, but a deep dive into its Q2 financials reveals the high-stakes reality of its path to profitability.

Cleveland's CHAMP skyrocketed 1,852 spots on the Inc. 5000 list. Here's how its systems-based approach is dismantling paper-based bureaucracy.

Making the Inc. 5000 once is hard. Four times? Levitate's success shows its 'relationship-first' model is more than a trend—it's a new benchmark.

Fisent Technologies just secured $4.3M to solve GenAI’s biggest problem in regulated industries: trust. Here’s how they plan to do it.

A five-year growth streak for one tech firm signals a massive structural shift. Nonprofits are adopting the tools of modern industry to build a new engine for generosity.

Cross-Border Impact Ventures secures a $58M first close for its second fund, targeting the vastly underserved but rapidly growing women's and children's health market.

SecureTech Innovations touts a new auditor and financial restatement as proof of discipline for its Nasdaq ambitions. But a closer look reveals material weaknesses and missed deadlines.

By wiping its balance sheet clean, Lode Gold signals its turnaround is complete. Now, the junior miner turns its focus to reviving a storied California mine.